BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5816028)

  • 1. Simultaneous extraction of tissue norepinephrine and serotonin.
    Phillips BM; Kraus PJ; Hammes TL; Leeling JL
    J Pharm Sci; 1969 May; 58(5):572-4. PubMed ID: 5816028
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and functional evaluation of the sympathectomy produced by the administration of guanethidine to newborn rats.
    Johnson EM; Cantor E; Douglas JR
    J Pharmacol Exp Ther; 1975 May; 193(2):503-12. PubMed ID: 238023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New norepinephrine-depleting agents. Beta-hydroxyphenethylguanidine and related compounds.
    Green AL; Fielden R; Bartlett DC; Cozens MJ; Eden RJ; Hills DW
    J Med Chem; 1967 Nov; 10(6):1006-8. PubMed ID: 6056024
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of guanethidine on rat brain serotonin and norepinephrine.
    Cox RH; Maickel RP
    Life Sci; 1969 Dec; 8(23):1319-24. PubMed ID: 5360061
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of sympathetic blocking agents on the uterine response to estrogen.
    Barnea A
    Endocrinology; 1969 Apr; 84(4):746-57. PubMed ID: 4387949
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism of tissue norepinephrine depletion by alpha, alpha'-dipyridyl.
    Bapna J; Neff NH; Costa E
    Neuropharmacology; 1970 Jul; 9(4):333-40. PubMed ID: 5456579
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of alpha-methyldopa, reserpine, guanethidine, and iproniazid on minimum alveolar anesthetic requirement (MAC).
    Miller RD; Way WL; Eger EI
    Anesthesiology; 1968; 29(6):1153-8. PubMed ID: 5726752
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of some organotin compounds on tissue amine levels in rats.
    Robinson IM
    Food Cosmet Toxicol; 1969 Jan; 7(1):47-52. PubMed ID: 5786927
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the dual action of guanethidine in sympathetic nerves.
    Lundborg P; Stitzel RE
    Acta Physiol Scand; 1968; 72(1):100-7. PubMed ID: 5655744
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of the noradrenaline-depleting and sympathetic-blocking actions of guanethidine and (-)-beta-hydroxyphenethylguanidine.
    Fielden R; Green AL
    Br J Pharmacol Chemother; 1967 May; 30(1):155-65. PubMed ID: 6039969
    [No Abstract]   [Full Text] [Related]  

  • 12. An automated method for determination of noradrenaline and adrenaline in tissues and biological fluids.
    Martin LE; Harrison C
    Anal Biochem; 1968 Jun; 23(3):529-45. PubMed ID: 5690572
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract]   [Full Text] [Related]  

  • 14. Norepinephrine and serotonin in the tissues and venoms of 2 pit vipers.
    Anton AH; Gennaro JF
    Nature; 1965 Dec; 208(5016):1174-5. PubMed ID: 5870315
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of hydrazinophthalazines on catecholamines in rats.
    Linet O; Van Zwieten PA; Hertting G
    Eur J Pharmacol; 1969 May; 6(2):121-4. PubMed ID: 5796797
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of reserpine and its derivatives on blood pressure and amine content].
    Fujiwara M; Osumi S; Tagashira E; Kurashashi K; Kajikawa H
    Nihon Yakurigaku Zasshi; 1970 Sep; 66(5):564-85. PubMed ID: 5529895
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of reserpine on the urinary excretion and the tissue levels of noradrenaline in the rat.
    Andén NE; Henning M
    Acta Physiol Scand; 1968; 72(1):134-8. PubMed ID: 5655745
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of ethyl 3-acetamido-4H-pyrrolo[3,4-c]-isoxazole-5(6H)carboxylate on tissue levels of catecholamines and 5-hydroxytryptamine in the rat.
    Lippmann W; Wishnick M
    J Pharm Pharmacol; 1967 Dec; 19(12):855-6. PubMed ID: 4383657
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of neurogenic amines to aggregation and strangers.
    Bliss EL; Ailion J
    J Pharmacol Exp Ther; 1969 Aug; 168(2):258-63. PubMed ID: 5816819
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolism of 3-(2-acetoxyethyl)-5-methoxyindole(5-methoxytryptophol o-acetate).
    Delvigs P; Taborsky RG
    Biochem Pharmacol; 1967 Mar; 16(3):579-86. PubMed ID: 6034374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.